Emmessar Biotech & Nutrition Limited

BSE:524768 Stock Report

Market Cap: ₹233.2m

Emmessar Biotech & Nutrition Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 524768?
Owner TypeNumber of SharesOwnership Percentage
Institutions2000.004%
Individual Insiders1,476,34929.6%
General Public1,642,99832.9%
Private Companies1,876,55337.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 23 shareholders own 67.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.8%
Emmessar Technologies Limited
1,088,553₹50.8m0%no data
10.6%
Manar Leasing & Investment Pvt Ltd
528,000₹24.6m0%no data
5.68%
Mathurakavi Srinivasa Ayyangar
283,933₹13.3m0%no data
5.37%
Heena Shah
268,100₹12.5m0%no data
5.37%
Hema Shah
268,100₹12.5m0%no data
5.2%
Amu Investment & Finance Pvt Ltd
260,000₹12.1m0%no data
3.41%
Rajalakshmi Raghavan
170,413₹8.0m0%no data
2.45%
Arvind Shah
122,633₹5.7m0%no data
1.92%
Sandeep Rao
96,081₹4.5m8.33%no data
1.59%
Vijaykumar Agrawal
79,477₹3.7m0%no data
0.91%
Bhavik Shah
45,500₹2.1m0%no data
0.76%
Jyothi Malla
38,100₹1.8m0%no data
0.52%
Sarada Raghavan
26,228₹1.2m0%no data
0.37%
Satyanarayana Malla
18,500₹863.6k0%no data
0.33%
Aman Shah
16,384₹764.8k0%no data
0.29%
Prabha Agrawal
14,500₹676.9k0%no data
0.29%
Prabha Agarwal
14,500₹676.9k0%no data
0.1%
M. Vijay Kumar
5,000₹233.4k0%no data
0.1%
T.A.V. Mohan
5,000₹233.4k0%no data
0.07%
Vasudevan Raghavan
3,500₹163.4k0%no data
0.004%
Ignatius Pereira
200₹9.3k0%no data
0.004%
Jeyavel Nadar
200₹9.3k0%no data
0.004%
Amu Shares & Securities Ltd, Asset Management Arm
200₹9.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 17:08
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Emmessar Biotech & Nutrition Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution